Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA5270396
Max Phase: Preclinical
Molecular Formula: C56H57N7O6
Molecular Weight: 924.12
Associated Items:
ID: ALA5270396
Max Phase: Preclinical
Molecular Formula: C56H57N7O6
Molecular Weight: 924.12
Associated Items:
Canonical SMILES: Nc1cc(C(=O)N2C[C@@H](C(=O)N[C@H]3C[C@@H]3c3ccccc3)[C@H](C(=O)N[C@H]3C[C@@H]3c3ccccc3)C2)ccc1C(=O)N1C[C@@H](C(=O)N[C@H]2C[C@@H]2c2ccccc2)[C@H](C(=O)N[C@H]2C[C@@H]2c2ccccc2)C1
Standard InChI: InChI=1S/C56H57N7O6/c57-46-23-36(55(68)62-28-42(51(64)58-47-24-38(47)32-13-5-1-6-14-32)43(29-62)52(65)59-48-25-39(48)33-15-7-2-8-16-33)21-22-37(46)56(69)63-30-44(53(66)60-49-26-40(49)34-17-9-3-10-18-34)45(31-63)54(67)61-50-27-41(50)35-19-11-4-12-20-35/h1-23,38-45,47-50H,24-31,57H2,(H,58,64)(H,59,65)(H,60,66)(H,61,67)/t38-,39-,40-,41-,42-,43-,44-,45-,47+,48+,49+,50+/m1/s1
Standard InChI Key: MNWBOJOXZHPRQY-NGNRVXSZSA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 924.12 | Molecular Weight (Monoisotopic): 923.4370 | AlogP: 5.33 | #Rotatable Bonds: 14 |
Polar Surface Area: 183.04 | Molecular Species: NEUTRAL | HBA: 7 | HBD: 5 |
#RO5 Violations: 2 | HBA (Lipinski): 13 | HBD (Lipinski): 6 | #RO5 Violations (Lipinski): 4 |
CX Acidic pKa: | CX Basic pKa: 1.63 | CX LogP: 4.24 | CX LogD: 4.24 |
Aromatic Rings: 5 | Heavy Atoms: 69 | QED Weighted: 0.09 | Np Likeness Score: -0.40 |
1. Kaur A, Kaushik D, Piplani S, Mehta SK, Petrovsky N, Salunke DB.. (2021) TLR2 Agonistic Small Molecules: Detailed Structure-Activity Relationship, Applications, and Future Prospects., 64 (1.0): [PMID:33346636] [10.1021/acs.jmedchem.0c01627] |
Source(1):